Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tigecycline”

61 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 61 results

Post-approval studies (Phase 4)Study completedNCT00419991
What this trial is testing

Open Label Non-comparative Clinical Trial of Tigecycline in Patients With Catheter Infection

Who this might be right for
Staphylococcal Infections
CPL Associates 10
Large-scale testing (Phase 3)Study completedNCT00079885
What this trial is testing

Study Evaluating Tigecycline vs Levofloxacin in Hospitalized With Community-Acquired Pneumonia

Who this might be right for
Community Acquired PneumoniaBacterial PneumoniaCross Infection
Wyeth is now a wholly owned subsidiary of Pfizer 430
Not applicableNot Yet RecruitingNCT06702943
What this trial is testing

Comparing Tigecycline Vs. Colistimethate in CNS Infections

Who this might be right for
Central Nervous System Infections
Ain Shams University 70
Not applicableUnknownNCT06049771
What this trial is testing

The Population Pharmacokinetics Study of Tigecycline and Pharmacokinetics- Pharmacodynamics Index in Patients With Carbapenem Resistant Enterobacteriaceae Bloodstream Infection

Who this might be right for
Carbapenem-resistant Enterobacteriaceae
Phramongkutklao College of Medicine and Hospital 72
Not applicableStudy completedNCT01789905
What this trial is testing

Tygacil Drug Use Investigation

Who this might be right for
Intra-Abdominal InfectionsSkin Disease, Infectious
Pfizer 116
Large-scale testing (Phase 3)Study completedNCT00079976
What this trial is testing

Study Evaluating Tigecycline in Selected Serious Infections Caused by Vancomycin-Resistant Enterococcus (VRE) or Methicillin-Resistant Staphylococcus Aureus (MRSA)

Who this might be right for
Gram-Positive Bacterial InfectionsStaphylococcus InfectionsVancomycin Resistance+1 more
Wyeth is now a wholly owned subsidiary of Pfizer 174
Not applicableStudy completedNCT07513103
What this trial is testing

Clinical Effectiveness of Tigecycline for Scrub Typhus.

Who this might be right for
Scrub Typhus
Jin Soo Lee 27
Not applicableStudy completedNCT01311349
What this trial is testing

Study Evaluating Local Susceptibility Patterns Associated With Tigecycline in Comparison to Other Antibiotics

Who this might be right for
Infection
Wyeth is now a wholly owned subsidiary of Pfizer 1,575
Post-approval studies (Phase 4)Study completedNCT00230971
What this trial is testing

Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)

Who this might be right for
AppendicitisCholecystitisDiverticulitis+3 more
Wyeth is now a wholly owned subsidiary of Pfizer 473
Post-approval studies (Phase 4)Study completedNCT01721408
What this trial is testing

Determine The Efficacy And Safety Of Tigecycline Compared With Imipenem/Cliastatin to Treat Complicated Intra-Abdominal Infection

Who this might be right for
Intra-abdominal Infection
Pfizer 470
Post-approval studies (Phase 4)Study completedNCT00368537
What this trial is testing

Study Comparing the Safety and Efficacy of Tigecycline With Ampicillin-Sulbactam or Amoxicillin-Clavulanate to Treat Skin Infections

Who this might be right for
Skin Diseases, Bacterial
Wyeth is now a wholly owned subsidiary of Pfizer 550
Large-scale testing (Phase 3)WithdrawnNCT00914888
What this trial is testing

Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia

Who this might be right for
Community Acquired Bacterial PneumoniaComplicated Intra-Abdominal Infection
Wyeth is now a wholly owned subsidiary of Pfizer
Post-approval studies (Phase 4)UnknownNCT04489459
What this trial is testing

Comparative Clinical Study Between Colistin-Tigecycline Combined Therapy Versus Colistin-Meropenem Combined Therapy in Treatment of Blood Stream Infections With Multidrug-Resistant Klebsiella Pneumoniae

Who this might be right for
Treatment of Blood Stream Infections Due to Multidrug-Resistant Klebsiella Pneumoniae
Al-Azhar University 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524920
What this trial is testing

Comparing Efficacy and Safety of (Meropenem + Colistin) Versus (Imipenem/Cilastatin + Tigecycline) on Eradication of Multi-Drug Resistance Bacteria

Who this might be right for
MDR Bacteria
Ain Shams University 60
Large-scale testing (Phase 3)Study completedNCT00080496
What this trial is testing

Study Evaluating Tigecycline Versus Imipenem/Cilastatin in Hospital-Acquired Pneumonia

Who this might be right for
Bacterial Pneumonia
Wyeth is now a wholly owned subsidiary of Pfizer 430
Not applicableStudy completedNCT00827541
What this trial is testing

Post-Authorization Study Evaluating Safety Of Tigecycline

Who this might be right for
Intra-Abdominal InfectionsSkin Disease, InfectiousSoft Tissues Infections
Pfizer 115
Testing effectiveness (Phase 2)Study completedNCT00600600
What this trial is testing

Tigecycline for Treatment of Rapidly Growing Mycobacteria

Who this might be right for
Mycobacterium Abscessus Lung DiseaseRapidly Growing Mycobacterial Lung Disease
The University of Texas Health Science Center at Tyler 8
Not applicableStudy completedNCT01401023
What this trial is testing

Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)

Who this might be right for
DiarrheaClostridium Difficile
Gary E. Stein, Pharm.D. 10
Post-approval studies (Phase 4)UnknownNCT01342731
What this trial is testing

Effectiveness and Safety of Tigecycline for Therapy of Infections Caused by Multi-Drug Resistant Acinetobacter Baumannii

Who this might be right for
Antibiotic Resistant Infection
Mahidol University 30
Post-approval studies (Phase 4)Study completedNCT01560143
What this trial is testing

Pharmacokinetics Of Tigecycline In Morbidly Obese Subjects

Who this might be right for
Obesity
Manjunath Prakash Pai 12
Next Page